 |
|
|
| |
Doravirine/Lamivudine/Tenofovir DF continues to be Non-Inferior to Efavirenz/Emtricitabine/Tenofovir DF in Treatment-naïve Adults with HIV-1 Infection: Week 96 Results of the DRIVE-AHEAD Trial
|
| |
| |
IDWeek 2018, October 3-7, 2018, San Francisco
Chloe Orkin1, Kathleen E. Squires2,7, Jean-Michel Molina3, Paul E. Sax4, Wing-Wai Wong5, Otto Sussmann6, Gina Lin7, Sushma Kumar7, George J. Hanna7, Carey Hwang7, Elizabeth Martin7, Hedy Teppler7 on behalf of the DRIVE-AHEAD study team
|
| |
|
|
|
|
|
